JERUSALEM--(BUSINESS WIRE)--Feb 5, 2010 - Teva Pharmaceutical Industries Ltd. announced today that several of its subsidiaries in the United States reached a settlement in principle to resolve claims brought by Ven-A-Care of the Florida Keys, Inc. on behalf of the United States, Texas, Florida, and California under federal and state False Claims Acts. [more]
WASHINGTON--(BUSINESS WIRE)--Feb 4, 2010 - ML Strategies and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. today announced the addition of Tom Koutsoumpas, a senior level executive with over 30 years of experience in government, public policy and issue advocacy at the federal and state levels. [more]
AUSTIN, TX, Feb. 4 /CNW Telbec/ - Akela (TSX: AKL) a leader in the development of therapeutics for the treatment of pain and its wholly owned subsidiary, PharmaForm, a leader in the contract pharmaceutical development and manufacturing business, today announced the outcomes of two legal cases involving former employees. [more]
SYRACUSE, N.Y., Feb. 3 /PRNewswire-USNewswire/ -- U.S. Attorney Richard S. Hartunian and FBI Special Agent in Charge John Pikus today announced the arrest of Shalin Jhaveri, 29, of Syracuse, N.Y. Jhaveri is charged by complaint with stealing trade secrets and proprietary information from his employer, Bristol-Myers-Squibb in violation of Title 18 U.S. Code Section 1832. If convicted, Jhaveri faces up to 10 years in prison and a $250,000 fine. Jhaveri appeared today before U.S. Magistrate Judge George H. Lowe and was ordered held without bail. A detention hearing is scheduled for Feb. 8, 2010 at 1:30 p.m. in Syracuse. [more]
NEW YORK--(BUSINESS WIRE)--Feb 3, 2010 - Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty and violations of state law in connection with the proposed sale of Global Med Technologies, Inc. (OTCBB: GLOB.OB- News) (referred to as "Global Med" or the “Company”) Haemonetics Corp. [more]
NATICK, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced the settlement of three patent disputes with Johnson & Johnson (J&J). [more]
BRIDGEWATER, N.J., Feb. 1 /PRNewswire/ -- Cordis Corporation, a Johnson & Johnson company, announced today that it has reached an agreement with Boston Scientific resolving two Delaware litigations related to Cordis's Palmaz and Gray patents and Boston Scientific's Jang patents. [more]
GOTHENBURG, Sweden, February 1/PRNewswire/ -- Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow HT System. [more]
JACKSON, Miss., Jan. 30 /PRNewswire-USNewswire/ -- Mississippians are expressing outrage at lawmakers' rush to change over-the-counter cold and allergy medicines containing pseudoephedrine (PSE) to a prescription (Rx) drug. [more]
FRANKFORT, Ky, Jan. 28, 2010--For the second time this week, Attorney General Jack Conway is announcing stiff civil penalties against a drug manufacturer for violating Kentucky's Consumer Protection Act. On Wednesday, January 27, 2010, Franklin Circuit Judge Roger Crittenden awarded the Commonwealth more than $5.8 million in civil penalties in its case against GlaxoSmithKline (GSK), for deceptive or false marketing of the anti-nausea drugs Kytril and Zofran, among others. [more]
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jan 28, 2010 - Gilead Sciences, Inc. (Nasdaq:GILD) today announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Viread® (tenofovir disoproxil fumarate). [more]
INKSTER, Mich., Jan. 28 /PRNewswire/ -- On January 28, 2010, Inkster resident Ashia Moore filed the first Yaz Birth Control Pill lawsuit in Michigan against Bayer Corporation in the United States District Court for the Eastern District, as a result of injuries sustained from the defendant's product. [more]
SAN DIEGO--(BUSINESS WIRE)--Jan 28, 2010 - Robbins Umeda LLP has commenced an investigation into possible mismanagement of KV Pharmaceutical Company ("KV" or the "Company") (NYSE: KV-A). KV, a fully-integrated specialty pharmaceutical company, develops, manufactures, acquires, and markets technology-differentiated branded and generic/non-branded prescription pharmaceutical products. The Company is based in St. Louis, Missouri. [more]
Jerusalem, Israel, January 26, 2010 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Schering-Plough's brain tumor treatment Temodar (temozolomide). The Court found that U.S. Patent No. 5,260,291 is not enforceable due to prosecution laches and inequitable conduct. [more]
WHITEHOUSE STATION, N.J., Jan. 26, 2010 – Merck & Co., Inc. announced today that the U.S. District Court for the District of Delaware ruled against the company in a patent infringement suit against Teva Pharmaceuticals USA Inc. [more]
TEANECK, N.J., Jan. 26 /PRNewswire/ -- Amy Yueh, the organizer of the Pharma CI Conference, who was sued in 2008 for alleged misappropriation of her employer's assets, has made payment of $52,000 by court order following judgment entered against her in the Superior Court of New Jersey. Yueh's trial took place in Hackensack, NJ. [more]
JERUSALEM, Israel--(BUSINESS WIRE)--Jan 22, 2010 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a Nov. 10, 2009, District Court decision that the Company's generic version of Takeda's Prevacid® (lansoprazole) SoluTab does not infringe U.S. Patent No. 5,464,632. [more]
NATICK, Mass., Jan. 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) announced today that the U.S. District Court for the District of Delaware has found all four patents in a suit involving Johnson & Johnson to be invalid. [more]
WASHINGTON, January 15, 2010 — The United States has filed a civil False Claims Act complaint against drug manufacturer Johnson & Johnson (J&J) of New Brunswick, N.J., and two of its subsidiaries, Ortho-McNeil-Janssen Pharmaceuticals Inc. and Johnson & Johnson Health Care Systems Inc., the Justice Department announced today. [more]
BOSTON, Mass., Jan. 14, 2010 - The former chief of acute pain at Bay State Hospital in Springfield, Massachuestts was charged today in federal court with falsifying medical research studies, including studies that were published in medical journals regarding pain management. [more]
Mergers & Acquisitions, Partnerships, & Collaborations 2010 – Review and Outlook
This PharmaLive Special Report analyzes the healthcare industry’s M&As of 2009, providing a comprehensive listing of companies’ M&A activity and detailing the top 20 deals within each of the Pharmaceutical, Biotechnology, Specialty, and Medical Device sectors, and previews potential M&A activity within the healthcare arena for 2010.
The introductory rate of $395 expires February 17, 2010.
